Remix Therapeutics aims to transform patients' lives by modulating RNA processing. The company focuses on developing small molecules that can influence the expression of mRNAs and proteins associated with various diseases, particularly those with high unmet medical needs. Remix is dedicated to advancing new therapeutic options and has established a rigorous commitment to scientific integrity and urgency, recognizing the critical need for effective treatments among patients. With a proprietary technology platform, Remix has rapidly initiated multiple drug discovery programs progressing towards clinical application. The organization emphasizes collaboration, diversity, and inclusion, fostering a culture where innovative research is pivotal to their mission of delivering impactful therapies.